Carrier advocacy coverage letter for uterine fibroid and uterine artery embolization for the treatment of Uterine Fibroids and Adenomyosis
This product is provided in a downloadable PDF format.
The uterine artery embolization (UAE) as a treatment for adenomyosis evidence-based letter was written by IR physicians who are members of SIR's Carrier Advocacy Workgroup. The letter is intended to help IRs during the authorization, appeal or denial process with any payor denying this service.
Policy coverage topic: Uterine artery embolization (UAE) for the treatment of adenomyosis.
A subscription model applies to this product. The text, graphics and information are of a general nature; it is not a substitute for obtaining medical advice. We may update the documents at any time without prior notice.